Narwhal Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9M Sell
94,177
-434
-0.5% -$101K 1.65% 14
2026
Q1
$23.1M Sell
94,611
-1,170
-1% -$273K 1.71% 11
2025
Q4
$19.8M Sell
95,781
-590
-0.6% -$117K 1.44% 17
2025
Q3
$17.9M Buy
96,371
+15,755
+20% +$2.7M 1.32% 18
2025
Q2
$12.3M Sell
80,616
-22,308
-22% -$3.43M 0.99% 25
2025
Q1
$17.1M Buy
102,924
+2,908
+3% +$455K 1.52% 18
2024
Q4
$14.5M Buy
100,016
+2,150
+2% +$333K 1.28% 21
2024
Q3
$15.9M Sell
97,866
-14,227
-13% -$2.27M 1.43% 19
2024
Q2
$16.4M Buy
112,093
+4,722
+4% +$702K 1.55% 15
2024
Q1
$17M Buy
107,371
+7,904
+8% +$1.26M 1.66% 13
2023
Q4
$15.6M Buy
99,467
+8,106
+9% +$1.24M 1.7% 13
2023
Q3
$14.2M Buy
91,361
+6,324
+7% +$1.04M 1.74% 12
2023
Q2
$14.1M Buy
85,037
+7,465
+10% +$1.2M 1.65% 13
2023
Q1
$12M Sell
77,572
-9,180
-11% -$1.48M 1.5% 18
2022
Q4
$15.3M Buy
86,752
+2,168
+3% +$374K 2.04% 10
2022
Q3
$13.8M Sell
84,584
-1,302
-2% -$220K 2% 11
2022
Q2
$15.2M Sell
85,886
-6,823
-7% -$1.22M 2.09% 10
2022
Q1
$16.4M Sell
92,709
-5,136
-5% -$874K 1.92% 12
2021
Q4
$16.7M Buy
97,845
+165
+0.2% +$27K 1.9% 15
2021
Q3
$15.8M Buy
97,680
+7,722
+9% +$1.32M 1.99% 13
2021
Q2
$14.8M Buy
89,958
+1,286
+1% +$213K 1.87% 13
2021
Q1
$14.6M Buy
88,672
+4,274
+5% +$692K 1.97% 13
2020
Q4
$13.3M Buy
84,398
+9,964
+13% +$1.47M 1.88% 13
2020
Q3
$11.1M Buy
74,434
+965
+1% +$143K 1.79% 15
2020
Q2
$10.3M Buy
73,469
+1,643
+2% +$239K 1.79% 14
2020
Q1
$9.42M Buy
71,826
+11,046
+18% +$1.57M 2.03% 12
2019
Q4
$8.87M Buy
60,780
+4,444
+8% +$603K 1.63% 14
2019
Q3
$7.29M Buy
56,336
+463
+0.8% +$61K 1.47% 18
2019
Q2
$7.78M Buy
55,873
+8,091
+17% +$1.12M 1.61% 16
2019
Q1
$6.68M Buy
47,782
+7,911
+20% +$1.06M 1.45% 19
2018
Q4
$5.14M Buy
39,871
+1,135
+3% +$158K 1.27% 24
2018
Q3
$5.35M Sell
38,736
-2,181
-5% -$290K 1.18% 22
2018
Q2
$4.96M Buy
40,917
+1,010
+3% +$126K 1.15% 23
2018
Q1
$5.11M Buy
39,907
+76
+0.2% +$10.3K 1.19% 23
2017
Q4
$5.57M Sell
39,831
-2,726
-6% -$380K 1.28% 21
2017
Q3
$5.53M Sell
42,557
-425
-1% -$56.3K 1.37% 15
2017
Q2
$5.69M Hold
42,982
1.47% 12
2017
Q1
$5.35M Buy
42,982
+150
+0.4% +$17.9K 1.49% 14
2016
Q4
$4.93M Hold
42,832
1.49% 15
2016
Q3
$5.06M Hold
42,832
1.58% 11
2016
Q2
$5.2M Hold
42,832
1.63% 9
2016
Q1
$4.63M Buy
42,832
+730
+2% +$75.6K 1.51% 10
2015
Q4
$4.33M Hold
42,102
1.5% 12
2015
Q3
$3.93M Buy
42,102
+1,230
+3% +$119K 1.47% 12
2015
Q2
$3.98M Buy
40,872
+1,636
+4% +$164K 1.45% 14
2015
Q1
$3.95M Sell
39,236
-1,045
-3% -$106K 1.44% 14
2014
Q4
$4.21M Sell
40,281
-2,240
-5% -$236K 1.63% 10
2014
Q3
$4.53M Sell
42,521
-250
-0.6% -$25.9K 1.82% 7
2014
Q2
$4.47M Sell
42,771
-2,082
-5% -$210K 1.71% 7
2014
Q1
$4.41M Sell
44,853
-1,050
-2% -$97.3K 1.83% 5
2013
Q4
$4.2M Sell
45,903
-150
-0.3% -$13.8K 1.73% 7
2013
Q3
$3.99M Sell
46,053
-500
-1% -$44.9K 1.91% 5
2013
Q2
$4M Buy
+46,553
New +$3.95M 1.93% 6

Other funds holding JNJ

Narwhal Capital Management's JNJ Position: Q2 2026 in Review

Narwhal Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.46% in Q2 2026, selling an estimated $101K and leaving 94,177 shares worth $23.9M. The position accounts for 1.65% of the portfolio, ranked #14.

Narwhal Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Narwhal Capital Management held 94,177 shares of Johnson & Johnson worth $23.9M as of Q2 2026.
  • Narwhal Capital Management sold 434 Johnson & Johnson shares in Q2 2026, an estimated $101K.
  • Johnson & Johnson made up 1.65% of Narwhal Capital Management's portfolio in Q2 2026, its #14 holding.
  • Narwhal Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.